Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to disease progression, is important to guide preventative treatment and improve outcomes. Blood eosinophils are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Wedzicha, Jadwiga A., Siddiqui, Salman, de la Hoz, Alberto, Xue, Wenqiong, Magnussen, Helgo, Miravitlles, Marc, Chalmers, James D., Calverley, Peter M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499955/
https://www.ncbi.nlm.nih.gov/pubmed/32943047
http://dx.doi.org/10.1186/s12931-020-01482-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499955/
https://www.ncbi.nlm.nih.gov/pubmed/32943047
http://dx.doi.org/10.1186/s12931-020-01482-1

Ejemplares similares